Cargando…

Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid–femoral pulse wave velocity in hemodialysis patients: a cross sectional study

BACKGROUND: Cardiovascular morbidity and mortality are highly prevalent in patients with end-stage renal disease, and osteoprotegerin (OPG) may be an important link between bone loss and vascular calcification. This study was conducted to evaluate the relationship between central arterial stiffness...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Jia-Sian, Lin, Yu-Li, Wang, Chih-Hsien, Lai, Yu-Hsien, Kuo, Chiu-Huang, Subeq, Yi-Maun, Hsu, Bang-Gee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533647/
https://www.ncbi.nlm.nih.gov/pubmed/31122190
http://dx.doi.org/10.1186/s12882-019-1374-2
_version_ 1783421246180950016
author Hou, Jia-Sian
Lin, Yu-Li
Wang, Chih-Hsien
Lai, Yu-Hsien
Kuo, Chiu-Huang
Subeq, Yi-Maun
Hsu, Bang-Gee
author_facet Hou, Jia-Sian
Lin, Yu-Li
Wang, Chih-Hsien
Lai, Yu-Hsien
Kuo, Chiu-Huang
Subeq, Yi-Maun
Hsu, Bang-Gee
author_sort Hou, Jia-Sian
collection PubMed
description BACKGROUND: Cardiovascular morbidity and mortality are highly prevalent in patients with end-stage renal disease, and osteoprotegerin (OPG) may be an important link between bone loss and vascular calcification. This study was conducted to evaluate the relationship between central arterial stiffness and serum OPG levels in hemodialysis (HD) patients. METHODS: Blood samples were collected from 120 HD patients, and the carotid–femoral pulse wave velocity (cfPWV) value was measured using a validated tonometry system. The cfPWV value of > 10 m/s was used to define the high artery stiffness group. Serum OPG levels were analyzed categorically into tertiles. RESULTS: Of the 120 HD patients, 53 (44.2%) were defined as the high arterial stiffness group, who had higher values of systolic blood pressure (p = 0.038), serum calcium (p = 0.007), and OPG (p <  0.001) levels and a higher prevalence of diabetes mellitus (DM, p = 0.001). Increasing tertiles of serum OPG levels were significantly associated with greater height (p = 0.011), male gender (p = 0.008), higher cfPWV values (p = 0.020), and lower intact parathyroid hormone (iPTH, p = 0.049) levels. Multivariable linear regression analysis showed that cfPWV value was independently associated with DM (β = 1.83, p = 0.008) and increasing tertiles of serum OPG levels (β = 0.89 and 1.63 for tertile 2 and tertile 3, respectively, p for trend = 0.035) in HD patients. Multivariable logistic regression analysis revealed that, in addition to age, DM, low iPTH levels, and high serum calcium levels, increasing tertiles of serum OPG levels (OR = 5.34 for tertile 2; OR = 7.06 for tertile 3; p for trend = 0.002) were an independent predictor of high arterial stiffness in HD patients. Serum calcium levels positively correlated with cfPWV value only in the highest OPG tertile group (r = 0.408, p = 0.009). CONCLUSION: A positive association was detected between serum OPG levels and central arterial stiffness in HD patients, and patients with high serum OPG levels may have greater influence of calcium load on central arterial stiffening.
format Online
Article
Text
id pubmed-6533647
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65336472019-05-29 Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid–femoral pulse wave velocity in hemodialysis patients: a cross sectional study Hou, Jia-Sian Lin, Yu-Li Wang, Chih-Hsien Lai, Yu-Hsien Kuo, Chiu-Huang Subeq, Yi-Maun Hsu, Bang-Gee BMC Nephrol Research Article BACKGROUND: Cardiovascular morbidity and mortality are highly prevalent in patients with end-stage renal disease, and osteoprotegerin (OPG) may be an important link between bone loss and vascular calcification. This study was conducted to evaluate the relationship between central arterial stiffness and serum OPG levels in hemodialysis (HD) patients. METHODS: Blood samples were collected from 120 HD patients, and the carotid–femoral pulse wave velocity (cfPWV) value was measured using a validated tonometry system. The cfPWV value of > 10 m/s was used to define the high artery stiffness group. Serum OPG levels were analyzed categorically into tertiles. RESULTS: Of the 120 HD patients, 53 (44.2%) were defined as the high arterial stiffness group, who had higher values of systolic blood pressure (p = 0.038), serum calcium (p = 0.007), and OPG (p <  0.001) levels and a higher prevalence of diabetes mellitus (DM, p = 0.001). Increasing tertiles of serum OPG levels were significantly associated with greater height (p = 0.011), male gender (p = 0.008), higher cfPWV values (p = 0.020), and lower intact parathyroid hormone (iPTH, p = 0.049) levels. Multivariable linear regression analysis showed that cfPWV value was independently associated with DM (β = 1.83, p = 0.008) and increasing tertiles of serum OPG levels (β = 0.89 and 1.63 for tertile 2 and tertile 3, respectively, p for trend = 0.035) in HD patients. Multivariable logistic regression analysis revealed that, in addition to age, DM, low iPTH levels, and high serum calcium levels, increasing tertiles of serum OPG levels (OR = 5.34 for tertile 2; OR = 7.06 for tertile 3; p for trend = 0.002) were an independent predictor of high arterial stiffness in HD patients. Serum calcium levels positively correlated with cfPWV value only in the highest OPG tertile group (r = 0.408, p = 0.009). CONCLUSION: A positive association was detected between serum OPG levels and central arterial stiffness in HD patients, and patients with high serum OPG levels may have greater influence of calcium load on central arterial stiffening. BioMed Central 2019-05-23 /pmc/articles/PMC6533647/ /pubmed/31122190 http://dx.doi.org/10.1186/s12882-019-1374-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hou, Jia-Sian
Lin, Yu-Li
Wang, Chih-Hsien
Lai, Yu-Hsien
Kuo, Chiu-Huang
Subeq, Yi-Maun
Hsu, Bang-Gee
Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid–femoral pulse wave velocity in hemodialysis patients: a cross sectional study
title Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid–femoral pulse wave velocity in hemodialysis patients: a cross sectional study
title_full Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid–femoral pulse wave velocity in hemodialysis patients: a cross sectional study
title_fullStr Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid–femoral pulse wave velocity in hemodialysis patients: a cross sectional study
title_full_unstemmed Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid–femoral pulse wave velocity in hemodialysis patients: a cross sectional study
title_short Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid–femoral pulse wave velocity in hemodialysis patients: a cross sectional study
title_sort serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid–femoral pulse wave velocity in hemodialysis patients: a cross sectional study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533647/
https://www.ncbi.nlm.nih.gov/pubmed/31122190
http://dx.doi.org/10.1186/s12882-019-1374-2
work_keys_str_mv AT houjiasian serumosteoprotegerinisanindependentmarkerofcentralarterialstiffnessasassessedusingcarotidfemoralpulsewavevelocityinhemodialysispatientsacrosssectionalstudy
AT linyuli serumosteoprotegerinisanindependentmarkerofcentralarterialstiffnessasassessedusingcarotidfemoralpulsewavevelocityinhemodialysispatientsacrosssectionalstudy
AT wangchihhsien serumosteoprotegerinisanindependentmarkerofcentralarterialstiffnessasassessedusingcarotidfemoralpulsewavevelocityinhemodialysispatientsacrosssectionalstudy
AT laiyuhsien serumosteoprotegerinisanindependentmarkerofcentralarterialstiffnessasassessedusingcarotidfemoralpulsewavevelocityinhemodialysispatientsacrosssectionalstudy
AT kuochiuhuang serumosteoprotegerinisanindependentmarkerofcentralarterialstiffnessasassessedusingcarotidfemoralpulsewavevelocityinhemodialysispatientsacrosssectionalstudy
AT subeqyimaun serumosteoprotegerinisanindependentmarkerofcentralarterialstiffnessasassessedusingcarotidfemoralpulsewavevelocityinhemodialysispatientsacrosssectionalstudy
AT hsubanggee serumosteoprotegerinisanindependentmarkerofcentralarterialstiffnessasassessedusingcarotidfemoralpulsewavevelocityinhemodialysispatientsacrosssectionalstudy